Citrullination of fibronectin in rheumatoid arthritis synovial tissue

Rheumatology

Volumn 44, Issue 11, 2005, Pages 1374-1382

  Chang, X ^a,c   Yamada, R ^a,d   Suzuki, A ^a   Kochi, Y ^a   Sawada, T ^b   Yamamoto, K ^a,b  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Citrullination; Fibronectin; Integrin 1; Peptidylarginine deiminase 4 (PADI4, PAD4 or PAD5); Rheumatoid arthritis; Synovial tissue; VEGF

Indexed keywords

BETA INTEGRIN; CITRULLINE; FIBRONECTIN; PROTEIN ARGININE DEIMINASE; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL AGGREGATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ANTIGENS, CD29; APOPTOSIS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELLS, CULTURED; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; HL-60 CELLS; HUMANS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744516866     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei023     Document Type: Article

References (50)

1. Vossenaar ER, Zendman AJ, van Venrooij WJ. Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 2004;6:1-5.
2. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. Bioessays 2003;25:1106-18.
3. Suzuki A, Yamada R, Chang X et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;24:395-402.
4. Chang X, Yamada R, Suzuki A et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005;44:40-50.
5. Weinberg JB, Pippen AM, Greenberg CS. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:996-1005.
6. Sanchez-Pernaute O, Largo R, Calvo E, Alvarez-Soria MA, Egido J, Herrero-Beaumont G. A fibrin based model for rheumatoid synovitis. Ann Rheum Dis 2003;62:1135-8.
7. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis 1981;40:142-53.
8. Sanchez-Pernaute O, Lopez-Armada MJ, Calvo E et al. Fibrin generated in the synovial fluid activates intimal cells from their apical surface: A sequential morphological study in antigen-induced arthritis. Rheumatology 2003;42:19-25.
9. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002;115:3861-3.
10. Carsons S. Extra domain-positive fibronectins in arthritis: Wolf in sheep's clothing? Rheumatology 2001;40:721-3.
11. Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum 2000;29:252-65.
12. 2+. J Biol Chem 1995;270:26270-7.
13. Nishiuchi R, Murayama O, Fujiwara H et al. Characterization of the ligand-binding specificities of integrin alpha3 beta1 and alpha6 beta1 using a panel of purified laminin isoforms containing distinct alpha chains. J Biochem (Tokyo) 2003;134:497-504.
14. Sugawara K, Yoshizawa Y, Tzeng S, Epstein WL, Fukuyama K. Colorimetric determination of citrulline residues in proteins. Anal Biochem 1998;265:92-6.
15. Scott DL, Delamere JP, Walton KW. The distribution of fibronectin in the pannus in rheumatoid arthritis. Br J Exp Pathol 1981;62:362-8.
16. Matsubara T, Spycher MA, Ruttner JR, Fehr K. The localization of fibronectin in rheumatoid arthritis synovium by light and electron microscopic immunohistochemistry. Rheumatol Int 1983;3:153-9.
17. Vossenaar ER, Radstake TR, van der Heijden A et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81.
18. Lundberg K, Nijenhuis K, Vossenaar ER et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005;7:R458-67.
19. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.
20. Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004;50:3485-94.
21. Peters JH, Carsons S, Yoshida M et al. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2003; 5:R329-39.
22. Hino K, Shiozawa S, Kuroki Y et al. EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 1995;38:678-83.
23. Shiozawa K, Hino K, Shiozawa S. Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology 2001;40:739-42.
24. Elices MJ, Tsai V, Strahl D et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-16.
25. Claudepierre P, Allanore Y, Belec L, Larget-Piet B, Zardi L, Chevalier X. Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology 1999;38:1099-103.
26. Scott DL, Farr M, Crockson AP, Walton KW. Synovial fluid and plasma fibronectin levels in rheumatoid arthritis. Clin Sci (Lond) 1982;62:71-6.
27. Dutu A, Vlaicu-Rus V, Bolosiu HD, Parasca I, Cristea A. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases. Med Intern 1986;24:61-8.
28. Nishinarita S, Yamamoto M, Takizawa T, Hayakawa J, Karasaki M, Sawada S. Increased plasma fibronectin in patients with systemic lupus erythematosus. Clin Rheumatol 1990;9:214-9.
29. Pekhlivanov D, Altunkova I, Toncheva A. Fibronectin and its clinical significance in patients with osteoarthrosis, psoriatic arthropathy and chronic prostatis with a joint syndrome. Vutr Boles 1990;29:81-4.
30. Cutolo M, Accardo S, Cimmino MA, Rovida S. Plasma fibronectin in psoriatic arthritis subgroups. Clin Rheumatol 1984;3:129-36.
31. Polgar A, Falus A, Koo E et al. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology 2003;42:522-7.
32. Atta MS, Lim KL, Ala'deen DA, Powell RJ, Todd I. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus. Ann Rheum Dis 1995; 54:117-24.
33. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
34. Clavel G, Bessis N, Boissier MC. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003;70:321-6.
35. Lee SS, Joo YS, Kim WU et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001;19:321-4.
36. Wijelath ES, Murray J, Rahman S et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002;91:25-31.
37. Armulik A. Splice variants of human beta 1 integrins: Origin, biosynthesis and functions. Front Biosci 2002;7:d219-27.
38. Pap T. New insights into integrin signalling: Implications for rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2003; 5:154-5.
39. Miyake S, Yagita H, Maruyama T, Hashimoto H, Miyasaka N, Okumura K. Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J Exp Med 1993;177:863-8.
40. Nakayamada S, Saito K, Fujii K, Yasuda M, Tamura M, Tanaka Y. Beta1 integrin-mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas-mediated apoptosis. Arthritis Rheum 2003;48:1239-48.
41. Sarkissian M, Lafyatis R. Integrin engagement regulates proliferation and collagenase expression of rheumatoid synovial fibroblasts. J Immunol 1999;162:1772-9.
42. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001;189:1-13.
43. Terui Y, Furukawa Y, Sakai T et al. Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. J Immunol 1996;156:1981-8.
44. Yasuda T, Kakinuma T, Julovi SM et al. COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology 2004;43:1116-20.
45. Yasuda T, Poole AR, Shimizu M et al. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture. Arthritis Rheum 2003;48:1271-80.
46. Yasuda T, Shimizu M, Nakagawa T, Julovi SM, Nakamura T. Matrix metalloproteinase production by COOH-terminal heparin-binding fibronectin fragment in rheumatoid synovial cells. Lab Invest 2003; 83:153-62.
47. Yasuda T, Poole AR. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 2002;46:138-48.
48. Esnault S, Malter JS. Hyaluronic acid or TNF-alpha plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins. J Immunol 2003;171:6780-7.
49. Esnault S, Malter JS. Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-alpha plus fibronectin-activated peripheral blood eosinophils. Blood 2002;99:4048-52.
50. Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology 2005;44:293-8.